About Astal Laboratories Limited
Data last updated: 14 July 2026
Astal Laboratories Limited is a public limited company based in Noida, Uttar Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 August 1993, the company has been in operation for over 33 years.
Registered with ROC Uttar Pradesh under CIN L16001UP1993PLC015605. Listed on BSE: 512600.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹43.8 Cr. Formerly known as Macro (International) Exports Limited. It is led by directors including Birendrakumar Sahoo and Sudheer Karna Kankanala.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: Office No. B7 A – 40 Sector 4, Noida, Uttar Pradesh, India – 201301.
As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹249.13 Cr. The net worth stands at ₹333.76 Cr. Total assets are valued at ₹518.19 Cr.
The company is associated with 1 brand - Macro International. As per MCA filings, the company has open charges of ₹14.1 Cr and satisfied charges of ₹2.46 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website miel.co.in.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressOffice No. B7 A – 40 Sector 4, Noida, Uttar Pradesh, India – 201301
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Astal Laboratories Limited
Astal Laboratories Limited has one previous CIN (Corporate Identification Number): L16001UP1993PLC015605. The current CIN is L74120UP1993PLC015605, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74120UP1993PLC015605 | Current |
| L16001UP1993PLC015605 | Previous |
Associated Brands with Astal Laboratories Limited
Astal Laboratories Limited operates one associated brand: Macro International. These brands represent Astal Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Multiple real estate strategies are focused on by the firm. | miel.co.in |
Business Activity of Astal Laboratories Limited
Astal Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Astal Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Astal Laboratories Limited
Astal Laboratories Limited is audited by M/s Sathuluri & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s Sathuluri & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Astal Laboratories Limited
Astal Laboratories Limited is currently managed by 7 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Birendrakumar Sahoo
Also directs:
Anand Life Sciences Llp, Manoharamma Hotel Investments Private Limited, Cytozon Technologies Private Limited and 3 more
|
Director | 24 May 2024 | 2 Years 1 Months | Current |
| Sudheer Karna Kankanala | Whole-Time Director | 08 Sep 2022 | 3 Years 10 Months | Current |
|
Ravikanti Shailaja
Also directs:
Dm Fincon Services Llp, Aceso Research Labs Llp
|
Director | 08 Sep 2022 | 3 Years 10 Months | Current |
| Hemachakrapani Bangaraiahgari | Director | 08 Sep 2022 | 3 Years 10 Months | Current |
| Julius Paul Reinhard Paschke | Director | 21 Dec 2024 | 1 Years 6 Months | Current |
|
Maggidi Venkatesh
Also directs:
Hemasree Life Science Llp, Exports Spark Alliance Llp
|
Director | 10 Jun 2023 | 3 Years 1 Months | Current |
Financials of Astal Laboratories Limited FY 2026 filings available
Astal Laboratories Limited reported revenue of ₹249.13 Cr for FY 2026.
| Metrics | FY 2026 |
|---|---|
| Revenue from Operations | ₹249.13 Cr |
| Other Income | ₹22.15 Lakh |
| Total Income | ₹249.35 Cr |
| Cost of Materials Consumed | ₹224.91 Cr |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | -₹5.89 Cr |
| Employee Benefit Expense | ₹5.02 Cr |
| Finance Costs | ₹2.03 Cr |
| Depreciation & Amortisation | ₹1.23 Cr |
| Other Expenses | ₹4.32 Cr |
| Total Expenses | ₹231.62 Cr |
| Profit Before Exceptional Items & Tax | ₹17.73 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹17.73 Cr |
| Total Tax Expense | ₹3.02 Cr |
| Net Profit | ₹14.71 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹14.71 Cr |
| EBITDA (computed) | ₹20.99 Cr |
| Basic EPS | ₹8.62 |
| Diluted EPS | ₹7.81 |
| Metrics | FY 2026 |
|---|---|
| Total Assets | ₹518.19 Cr |
| Non-current Assets | ₹274.7 Cr |
| Current Assets | ₹243.5 Cr |
| Property, Plant & Equipment | ₹63.71 Cr |
| Inventories | ₹67.52 Cr |
| Trade Receivables | ₹156.35 Cr |
| Cash & Equivalents | ₹1.3 Cr |
| Equity (Net Worth) | ₹333.76 Cr |
| Equity Share Capital | ₹42.23 Cr |
| Borrowings (Non-current) | ₹18.64 Cr |
| Borrowings (Current) | ₹30.44 Cr |
| Total Debt (computed) | ₹49.08 Cr |
| Current Liabilities | ₹164.29 Cr |
| Total Liabilities | ₹184.44 Cr |
| Metrics | FY 2026 |
|---|---|
| Operating Cash Flow | -₹17.7 Cr |
| Investing Cash Flow | -₹2.17 Cr |
| Financing Cash Flow | ₹2.58 Cr |
| Capital Expenditure | ₹1.39 Cr |
| Free Cash Flow (computed) | -₹19.09 Cr |
| Dividends Paid | ₹0 |
| Net Change in Cash | -₹17.29 Cr |
| Metrics | Q4 FY26 |
|---|---|
| Revenue from Operations | ₹134.05 Cr |
| Other Income | ₹9.62 Lakh |
| Total Income | ₹134.15 Cr |
| Cost of Materials Consumed | ₹108.25 Cr |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | ₹9.36 Cr |
| Employee Benefit Expense | ₹3.72 Cr |
| Finance Costs | ₹1.09 Cr |
| Depreciation & Amortisation | ₹86.08 Lakh |
| Other Expenses | ₹2.53 Cr |
| Total Expenses | ₹125.81 Cr |
| Profit Before Exceptional Items & Tax | ₹8.34 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹8.34 Cr |
| Total Tax Expense | ₹65.66 Lakh |
| Net Profit | ₹7.68 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹7.68 Cr |
| EBITDA (computed) | ₹10.29 Cr |
| Basic EPS | ₹2.04 |
| Diluted EPS | ₹1.95 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹156 Cr | ₹64.23 Cr | ₹23.65 Cr | ₹3.43 Cr | ₹0 | ₹20.31 Lakh | ₹0 | ₹0 |
| Other Income | ₹19.15 Lakh | ₹12.51 Lakh | ₹1.34 Lakh | ₹17.87 Lakh | ₹21.08 Lakh | ₹0 | ₹20.48 Lakh | ₹30.04 Lakh |
| Total Income | ₹156.19 Cr | ₹64.36 Cr | ₹23.66 Cr | ₹3.61 Cr | ₹21.08 Lakh | ₹20.31 Lakh | ₹20.48 Lakh | ₹30.04 Lakh |
| Cost of Materials Consumed | ₹152.88 Cr | ₹61.81 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹22.4 Cr | ₹3.35 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹14.02 Cr | -₹13.7 Cr | -₹1.06 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.11 Cr | ₹1.34 Cr | ₹46.57 Lakh | ₹6.48 Lakh | ₹8.52 Lakh | ₹6.19 Lakh | ₹9.48 Lakh | ₹7.09 Lakh |
| Finance Costs | ₹1.41 Cr | ₹70.07 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹68.84 Lakh | ₹22.31 Lakh | ₹2.95 Lakh | ₹79,000 | ₹1.45 Lakh | ₹1.55 Lakh | ₹1.55 Lakh | ₹1.58 Lakh |
| Other Expenses | ₹2.24 Cr | ₹2 Cr | ₹74.05 Lakh | ₹14.74 Lakh | ₹12.81 Lakh | ₹11.76 Lakh | ₹12.26 Lakh | ₹28.91 Lakh |
| Total Expenses | ₹145.32 Cr | ₹52.38 Cr | ₹22.57 Cr | ₹3.57 Cr | ₹22.78 Lakh | ₹19.5 Lakh | ₹23.29 Lakh | ₹37.58 Lakh |
| Profit Before Exceptional Items & Tax | ₹10.87 Cr | ₹11.98 Cr | ₹1.09 Cr | ₹3.21 Lakh | -₹1.7 Lakh | ₹81,000 | -₹2.81 Lakh | -₹7.54 Lakh |
| Exceptional Items | ₹0 | -₹1,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.87 Cr | ₹11.98 Cr | ₹1.09 Cr | ₹3.21 Lakh | -₹1.7 Lakh | ₹81,000 | -₹2.81 Lakh | -₹7.54 Lakh |
| Total Tax Expense | ₹2.75 Cr | ₹3.05 Cr | ₹30.19 Lakh | ₹1.57 Lakh | ₹1,000 | ₹21,000 | ₹1,000 | ₹67,000 |
| Net Profit | ₹8.12 Cr | ₹8.93 Cr | ₹78.47 Lakh | ₹1.64 Lakh | -₹1.71 Lakh | ₹60,000 | -₹2.82 Lakh | -₹8.21 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹8.12 Cr | ₹8.93 Cr | ₹78.47 Lakh | ₹1.64 Lakh | -₹1.71 Lakh | ₹60,000 | -₹2.82 Lakh | -₹8.21 Lakh |
| EBITDA (computed) | ₹12.96 Cr | ₹12.9 Cr | ₹1.12 Cr | ₹4 Lakh | -₹25,000 | ₹2.36 Lakh | -₹1.26 Lakh | -₹5.96 Lakh |
| Basic EPS | ₹4.76 | ₹9.08 | ₹1.55 | ₹0.04 | ₹0.00 | ₹0.02 | ₹0.00 | ₹0.00 |
| Diluted EPS | ₹4.31 | ₹8.04 | ₹1.55 | ₹0.04 | ₹0.00 | ₹0.02 | ₹0.00 | ₹0.00 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹399.57 Cr | ₹63.34 Cr | ₹36.61 Cr | ₹9.91 Cr | ₹5.23 Cr | ₹5.31 Cr | ₹5.27 Cr | ₹5.33 Cr |
| Non-current Assets | ₹296.31 Cr | ₹17.7 Cr | ₹9.89 Cr | ₹3.79 Cr | ₹8.23 Lakh | ₹6.01 Lakh | ₹14.06 Lakh | ₹15.61 Lakh |
| Current Assets | ₹103.26 Cr | ₹45.64 Cr | ₹26.73 Cr | ₹6.11 Cr | ₹5.15 Cr | ₹5.25 Cr | ₹5.13 Cr | ₹5.17 Cr |
| Property, Plant & Equipment | ₹11.36 Cr | ₹11.44 Cr | ₹69 Lakh | ₹56,000 | ₹1.35 Lakh | ₹0 | ₹6.86 Lakh | ₹8.41 Lakh |
| Inventories | ₹28.78 Cr | ₹14.76 Cr | ₹1.06 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹72.3 Cr | ₹27.66 Cr | ₹15.82 Cr | ₹3.17 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Cash & Equivalents | ₹69.6 Lakh | ₹1.73 Cr | ₹6.08 Cr | ₹8.44 Lakh | ₹1.83 Lakh | ₹3.13 Lakh | ₹1.45 Lakh | ₹82,000 |
| Equity (Net Worth) | ₹327.16 Cr | ₹35.99 Cr | ₹23.34 Cr | ₹5.18 Cr | ₹5.16 Cr | ₹5.18 Cr | ₹5.17 Cr | ₹5.2 Cr |
| Equity Share Capital | ₹42.23 Cr | ₹9.85 Cr | ₹9.85 Cr | ₹3.99 Cr | ₹3.99 Cr | ₹3.99 Cr | ₹3.99 Cr | ₹3.99 Cr |
| Borrowings (Non-current) | ₹36.59 Lakh | ₹45.61 Lakh | ₹25.74 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹11.59 Cr | ₹12.81 Cr | ₹5.48 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹11.96 Cr | ₹13.27 Cr | ₹31.22 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹71.11 Cr | ₹26.77 Cr | ₹13.01 Cr | ₹4.73 Cr | ₹6.89 Lakh | ₹13.16 Lakh | ₹7.72 Lakh | ₹13.25 Lakh |
| Total Liabilities | ₹72.41 Cr | ₹27.35 Cr | ₹13.27 Cr | ₹4.73 Cr | ₹6.89 Lakh | ₹13.16 Lakh | ₹10.08 Lakh | ₹13.25 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.08 Cr | -₹12.52 Cr | -₹5.59 Cr | -₹1.44 Cr | -₹24.87 Lakh |
| Investing Cash Flow | -₹1.28 Cr | -₹7.81 Cr | -₹6.12 Cr | ₹17.87 Lakh | ₹23.58 Lakh |
| Financing Cash Flow | ₹4.55 Cr | ₹3.29 Cr | ₹17.7 Cr | ₹1.32 Cr | ₹0 |
| Capital Expenditure | ₹40.72 Lakh | ₹0 | ₹71.39 Lakh | ₹0 | ₹0 |
| Free Cash Flow (computed) | -₹3.48 Cr | -₹12.52 Cr | -₹6.3 Cr | -₹1.44 Cr | -₹24.87 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹18.63 Lakh | -₹17.04 Cr | ₹5.99 Cr | ₹6.61 Lakh | -₹1.29 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹40.92 Cr | ₹52.24 Cr | ₹37.52 Cr | ₹25.33 Cr | ₹23.47 Cr | ₹14.46 Cr | ₹13.16 Cr | ₹13.15 Cr |
| Other Income | ₹6.62 Lakh | ₹3.65 Lakh | ₹3.27 Lakh | ₹5.61 Lakh | ₹3.5 Lakh | ₹5.59 Lakh | ₹0 | ₹3.42 Lakh |
| Total Income | ₹40.98 Cr | ₹52.27 Cr | ₹37.55 Cr | ₹25.38 Cr | ₹23.5 Cr | ₹14.51 Cr | ₹13.16 Cr | ₹13.18 Cr |
| Cost of Materials Consumed | ₹36.23 Cr | ₹54.49 Cr | ₹39.08 Cr | ₹23.08 Cr | ₹24.84 Cr | ₹12.28 Cr | ₹13.1 Cr | ₹11.59 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹1.23 Cr | -₹7.37 Cr | -₹6.26 Cr | -₹1.62 Cr | -₹6.49 Cr | -₹1.94 Cr | -₹3.6 Cr | -₹1.66 Cr |
| Employee Benefit Expense | ₹80.72 Lakh | ₹44 Lakh | ₹41.83 Lakh | ₹44.72 Lakh | ₹9.08 Lakh | ₹40.67 Lakh | ₹43.34 Lakh | ₹40.76 Lakh |
| Finance Costs | ₹46.72 Lakh | ₹33.21 Lakh | ₹30.91 Lakh | ₹30.08 Lakh | ₹26.58 Lakh | ₹28.08 Lakh | ₹9.13 Lakh | ₹6.29 Lakh |
| Depreciation & Amortisation | ₹32.1 Lakh | ₹12.48 Lakh | ₹12.24 Lakh | ₹12.01 Lakh | ₹10.41 Lakh | ₹8.13 Lakh | ₹2.5 Lakh | ₹1.28 Lakh |
| Other Expenses | ₹46.01 Lakh | ₹1.12 Cr | ₹40.95 Lakh | ₹25.59 Lakh | ₹83.95 Lakh | ₹39.57 Lakh | ₹34 Lakh | ₹42.9 Lakh |
| Total Expenses | ₹39.51 Cr | ₹49.14 Cr | ₹34.08 Cr | ₹22.59 Cr | ₹19.65 Cr | ₹11.5 Cr | ₹10.39 Cr | ₹10.84 Cr |
| Profit Before Exceptional Items & Tax | ₹1.47 Cr | ₹3.13 Cr | ₹3.47 Cr | ₹2.79 Cr | ₹3.85 Cr | ₹3.02 Cr | ₹2.77 Cr | ₹2.34 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1,000 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.47 Cr | ₹3.13 Cr | ₹3.47 Cr | ₹2.79 Cr | ₹3.85 Cr | ₹3.02 Cr | ₹2.77 Cr | ₹2.34 Cr |
| Total Tax Expense | ₹38.59 Lakh | ₹77.37 Lakh | ₹88.73 Lakh | ₹70.32 Lakh | ₹1.1 Cr | ₹52.93 Lakh | ₹76.98 Lakh | ₹64.93 Lakh |
| Net Profit | ₹1.09 Cr | ₹2.36 Cr | ₹2.58 Cr | ₹2.09 Cr | ₹2.74 Cr | ₹2.49 Cr | ₹2 Cr | ₹1.69 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹1.09 Cr | ₹2.36 Cr | ₹2.58 Cr | ₹2.09 Cr | ₹2.74 Cr | ₹2.49 Cr | ₹2 Cr | ₹1.69 Cr |
| EBITDA (computed) | ₹2.26 Cr | ₹3.59 Cr | ₹3.9 Cr | ₹3.21 Cr | ₹4.22 Cr | ₹3.38 Cr | ₹2.89 Cr | ₹2.41 Cr |
| Basic EPS | ₹0.29 | ₹2.19 | ₹2.40 | ₹2.12 | ₹2.80 | ₹2.53 | ₹2.04 | ₹1.72 |
| Diluted EPS | ₹0.27 | ₹1.74 | ₹1.97 | ₹1.73 | ₹1.76 | ₹2.53 | ₹2.04 | ₹1.72 |
Charges & Borrowings of Astal Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2024 | Canara Bank | ₹9 Cr | Open |
| 25 Apr 2024 | Canara Bank | ₹5.1 Cr | Open |
| 29 Sep 1997 | Canara Bank | ₹10 Lakh | Satisfied |
| 29 Sep 1997 | Canara Bank | ₹10 Lakh | Satisfied |
| 13 Mar 1996 | Canara Bank | ₹82 Lakh | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Astal Laboratories Limited
View historical data on people associated with Astal Laboratories Limited, including employment history and EPFO contributions.
Employee and EPFO history for Astal Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Astal Laboratories Limited
GST registrations and filing compliance for Astal Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Astal Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Astal Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Astal Laboratories Limited
MSME payment history for Astal Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Astal Laboratories Limited
Corporate group structure for Astal Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Astal Laboratories Limited
MCA filings and documents for Astal Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Astal Laboratories Limited
Frequently Asked Questions about Astal Laboratories Limited
Astal Laboratories Limited is an active public limited company in the pharma sector based in Noida, Uttar Pradesh, India. It was incorporated on 03 August 1993 (33+ years old) and is registered under CIN L74120UP1993PLC015605. Listed on BSE: 512600.
Astal Laboratories Limited reported revenue of ₹249.13 Cr for FY 2026 based on consolidated BSE filings.
The current directors of Astal Laboratories Limited are:
- Birendrakumar Sahoo - Director
- Sudheer Karna Kankanala - Whole-Time Director
- Ravikanti Shailaja - Director
- Hemachakrapani Bangaraiahgari - Director
- Julius Paul Reinhard Paschke - Director
- Maggidi Venkatesh - Director
- Radhakishore Pandrangi - Director
The primary industry of Astal Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Astal Laboratories Limited is listed on BSE with code 512600.
Astal Laboratories Limited can be reached at the registered office: Office No. B7 A – 40 Sector 4, Noida, Uttar Pradesh, India – 201301, or through the website miel.co.in.